Performance Plus Thermo
Performance Plus Thermo, licence 80081996: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- EFIL Inc.
- NPN or DIN-HM
- 80081996
- Status
- Active licence
- Licence date
- 21 December 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille Potency : 30.0 % Epigallocatechin 3-gallate | Not specified | Not calculated |
| Extrait de fève de café vert Source : Coffea arabica graine Potency : 50.0 % Chlorogenic acids | Not specified | Not calculated |
| L-Carnitine Source : L-tartrate de carnitine | 166.6 mg | Not calculated |
| Extrait de fève de café vert Source : Coffea arabica graine Extract : Matériel brut sec Extraction ratio : 1.001:1 Dry plant equivalent : 66.66 mg Potency : 2.0 % Caffeine | 66.6 mg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 2.5 mcg | 15 µg |
| Ilex paraguariensis Source : Ilex paraguariensis - feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 133.2 mg | 33.3 mg | Not calculated |
| Juniperus communis Source : Juniperus communis - Fruit | 50.0 mg | Not calculated |
Non-medicinal ingredients
Caséinate de sodium, Gélatine, Sirop de glucose, Pyrophosphate de tétrasodium, Tocophérols, Stéarate de magnésium, Maltodextrine, Cellulose microcristalline, Dioxyde de silicium, Lécithine, Dioxyde de titane, Bleu FD&C n° 1, Huile de carthame, Laque d'aluminium jaune FD&C No. 5, D-Mannitol, Huile végétale hydrogénée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 3.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidant(s)/Provides antioxidant(s) Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals Helps support fat metabolism Helps in energy production Helps normal growth Helps to prevent thiamine deficiency Helps to maintain the body's ability to metabolize nutrients Helps in energy metabolism and in tissue formation Helps to maintain healthy mucous membranes Helps to maintain normal metabolism of iron Helps to prevent riboflavin deficiency Helps to prevent vitamin B6 deficiency Helps in the normal function of the immune system Helps in energy metabolism in the body Helps to prevent vitamin B12 deficiency Provides support for healthy glucose metabolism Helps to prevent chromium deficiency
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80081996
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.